Erkin Ötleş

Dr. Erkin Ötleş

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2022 in Cell Reports Medicine
Verified
Journal Article
Open access
EÖErkin Ötleş
Erkin Ötleş
CJCornelius A. James
Cornelius A. James
KLKimberly D. Lomis
Kimberly D. Lomis
JWJames O. Woolliscroft
James O. Woolliscroft
Artificial intelligence (AI) is transforming the practice of medicine. Systems assessing chest radiographs, pathology slides, and early warning systems embedded in electronic health records (EHRs) are becoming ubiquitous in medical practice. Despite this, medical students have minimal exposure to the concepts necessary to utilize and evaluate AI systems, leaving them under prepared for future clinical practice. We must work quickly to bolster undergraduate medical education around AI to remedy this. In this commentary, we propose that medical educators treat AI as a critical component of medical practice that is introduced early and integrated with the other core components of medical school curricula. Equipping graduating medical students with this knowledge will ensure they have the skills to solve challenges arising at the confluence of AI and medicine.

1 November 2021 in Journal of Surgical Education
Verified
Journal Article
Closed access
KAKenneth L. Abbott
Kenneth L. Abbott
BGBrian C. George
Brian C. George
GSGurjit Sandhu
Gurjit Sandhu
CHCalista M. Harbaugh
Calista M. Harbaugh
PGPaul G. Gauger
Paul G. Gauger
JVJoceline V. Vu
Joceline V. Vu

29 April 2020 in medRxiv
Verified
Preprint
Open access
KSKarandeep Singh
Karandeep Singh
TVThomas S. Valley
Thomas S. Valley
STShengpu Tang
Shengpu Tang
BLBenjamin Y. Li
Benjamin Y. Li
FKFahad Kamran
Fahad Kamran
BNBrahmajee K. Nallamothu
Brahmajee K. Nallamothu
Introduction: The Epic Deterioration Index (EDI) is a proprietary prediction model implemented in over 100 U.S. hospitals that was widely used to support medical decision-making during the COVID-19 pandemic. The EDI has not been independently evaluated, and other proprietary models have been shown to be biased against vulnerable populations. Methods: We studied adult patients admitted with COVID-19 to non-ICU care at a large academic medical center from March 9 through May 20, 2020. We used the EDI, calculated at 15-minute intervals, to predict a composite outcome of ICU-level care, mechanical ventilation, or in-hospital death. In a subset of patients hospitalized for at least 48 hours, we also evaluated the ability of the EDI to identify patients at low risk of experiencing this composite outcome during their remaining hospitalization. Results: Among 392 COVID-19 hospitalizations meeting inclusion criteria, 103 (26%) met the composite outcome. Median age of the cohort was 64 (IQR 53-75) with 168 (43%) African Americans and 169 (43%) women. Area under the receiver-operating-characteristic curve (AUC) of the EDI was 0.79 (95% CI 0.74-0.84). EDI predictions did not differ by race or sex. When exploring clinically-relevant thresholds of the EDI, we found patients who met or exceeded an EDI of 68.8 made up 14% of the study cohort and had a 74% probability of experiencing the composite outcome during their hospitalization with a median lead time of 24 hours from when this threshold was first exceeded. Among the 286 patients hospitalized for at least 48 hours who had not experienced the composite outcome, 14 (13%) never exceeded an EDI of 37.9, with a negative predictive value of 90% and a sensitivity above this threshold of 91%. Conclusion: We found the EDI identifies small subsets of high- and low-risk COVID-19 patients with fair discrimination. We did not find evidence of bias by race or sex. These findings highlight the importance of independent evaluation of proprietary models before widespread operational use among COVID-19 patients.

23 September 2021 in Journal of Urology
Verified
Journal Article
Closed access
EÖErkin Ötleş
Erkin Ötleş
BDBrian T. Denton
Brian T. Denton
BQBo Qu
Bo Qu
AMAdharsh Murali
Adharsh Murali
SMSelin Merdan
Selin Merdan
KSKarandeep Singh
Karandeep Singh
Purpose:Prediction models are recommended by national guidelines to support clinical decision-making in prostate cancer. Existing models to predict pathologic outcomes of radical prostatectomy (RP)...

27 June 2023 in Journal of Surgical Education
Verified
Journal Article
Closed access
RGRebecca S. Gates
Rebecca S. Gates
KMKayla Marcotte
Kayla Marcotte
RMRebecca Moreci
Rebecca Moreci
BGBrian C. George
Brian C. George
GKGrace J. Kim
Grace J. Kim
AKAndrew E. Krumm
Andrew E. Krumm

24 April 2023 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
EÖErkin Ötleş
Erkin Ötleş
EBEmily A. Balczewski
Emily A. Balczewski
MKMicah Keidan
Micah Keidan
JOJeeheh Oh
Jeeheh Oh
APAlieysa Patel
Alieysa Patel
JWJenna Wiens
Jenna Wiens
Objective: Screening individuals admitted to the hospital for Clostridioides difficile presents opportunities to limit transmission and hospital-onset C. difficile infection (HO-CDI). However, detection from rectal swabs is resource intensive. In contrast, machine learning (ML) models may accurately assess patient risk without significant resource usage. In this study, we compared the effectiveness of swab surveillance to daily risk estimates produced by an ML model to identify patients who will likely develop HO-CDI in the intensive care unit (ICU) setting.Design: A prospective cohort study was conducted with patient carriage of toxigenic C. difficile identified by rectal swabs analyzed by anaerobic culture and polymerase chain reaction (PCR). A previously validated ML model using electronic health record data generated daily risk of HO-CDI for every patient. Swab results and risk predictions were compared to the eventual HO-CDI status.Patients: Adult inpatient admissions taking place in University of Michigan Hospitals’ medical and surgical intensive care units and oncology wards between June 6th and October 8th, 2020.Results: In total, 2,979 admissions, representing 2,044 patients, were observed over the course of the study period, with 39 admissions developing HO-CDIs. Swab surveillance identified 9 true-positive and 87 false-positive HO-CDIs. The ML model identified 9 true-positive and 226 false-positive HO-CDIs; 8 of the true-positives identified by the model differed from those identified by the swab surveillance.Conclusion: With limited resources, an ML model identified the same number of HO-CDI admissions as swab-based surveillance, though it generated more false-positives. The patients identified by the ML model were not yet colonized with C. difficile. Additionally, the ML model identifies at-risk admissions before disease onset, providing opportunities for prevention.